Skip to main content
. 2022 Mar 7;8:20552076221084458. doi: 10.1177/20552076221084458

Table 2.

Reported frequencies for LTHCs and primary LTHCs.

LTHC Number of reports Percentage of total LTHCs reported Percentage of sample Number reported as primary LTHC Percentage of sample reported as primary LTHC
Acne 16 2.4 6.4 1 .4
Alcohol problems 5 0.7 2.0 0 0
Anorexia or bulimia 2 0.3 0.8 0 0
Anxiety 87 12.9 34.8 13 5.2
Asthma 46 6.8 18.4 17 6.8
Atrial fibrillation 2 0.3 0.8 2 .8
Bronchiectasis 1 0.1 0.4 1 .4
Cancer 6 0.9 2.4 4 1.6
Cardiovascular disease 3 0.4 1.2 1 .4
Chronic fatigue syndrome 19 2.8 7.6 11 4.4
Chronic kidney disease 3 0.4 1.2 1 .4
COPD 2 0.3 0.8 2 .8
Chronic sinusitis 2 0.3 0.8 1 .4
Chronic tissue disorder 2 0.3 0.8 0 0
Coronary heart disease 2 0.3 0.8 2 .8
Depression 88 13.1 35.2 21 8.4
Diabetes (type 1) 7 1.0 2.8 6 2.4
Diabetes (type 2) 12 1.8 4.8 4 1.6
Diabetes (type not specified) 6 0.9 2.4 5 2.0
Diverticular disease 4 0.6 1.6 0 0
Dyspepsia 4 0.6 1.6 1 .4
Endometriosis 11 1.6 4.4 5 2.0
Epilepsy 5 0.7 2.0 3 1.2
Erectile dysfunction 2 0.3 0.8 0 0
Glaucoma 1 0.1 0.4 0 0
Heart failure 3 0.4 1.2 1 .4
Hypertension 19 2.8 7.6 6 2.4
Incontinence 2 0.3 0.8 1 .4
Inflammatory bowel disease 7 1.0 2.8 5 2.0
Irritable bowel syndrome 30 4.5 12.0 4 1.6
Meniere's disease 3 0.4 1.2 0 0
Mental health condition 35 5.2 14.0 6 2.4
Migraine 31 4.6 12.4 5 2.0
Multiple sclerosis 6 0.9 2.4 5 2.0
Obesity 24 3.6 9.6 2 .8
Osteoporosis 6 0.9 2.4 2 .8
Painful conditions 38 5.7 15.2 14 5.6
Parkinson's disease 1 0.1 0.4 1 .4
Pernicious anaemia 2 0.3 0.8 1 .4
Polycystic ovary 12 1.8 4.8 3 1.2
Prostate disorders 1 0.1 0.4 0 0
Psoriasis/eczema 30 4.5 12.0 4 1.6
Schizophrenia or bipolar disorder 5 0.7 2.0 2 .8
Sexual health condition 2 0.3 0.8 0 0
Stroke/transient ischaemic attack 1 0.1 0.4 1 .4
Thyroid disorder 16 2.4 6.4 8 3.2
Treated constipation 2 0.3 0.8 0 0
Other condition 58 8.6 23.2 31 12.4
Multiple long-term conditions 47 18.8
Total 672 100 268.8 250 100